Drug Topics
MARCH 19, 2024
The biotechnology company’s recombinant spike protein-based vaccine demonstrated an efficacy of 88% after 40 days, 82% after 120 days, and 77% after 180 days during the PREVENT-19 trial.
Pharmacy Times
MARCH 19, 2024
The agency will focus on collaboration to protect public health; advancing regulatory approaches; developing standards, guidelines, and best practices; and supporting research that evaluates and monitors AI performance.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 19, 2024
Moderna, Merck, and Pfizer-BioNTech are leading the charge with new vaccines for respiratory viruses in development.
STAT
MARCH 19, 2024
The news is everywhere in my social news feeds this morning: A popular fad diet is apparently lethal, scientific research says. Specifically, a study found that caloric restriction, also known as intermittent fasting, has a 91% risk of death due to cardiovascular disease. Except scientific research doesn’t say that — and not only should you not be worried about this study, you shouldn’t be wasting brain glucose thinking about it.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
MARCH 19, 2024
Google is doubling down on its ambitions for healthcare AI by exploring how generative AI can help clinicians in medical decision-making, understand lab and imaging information and provide con | Google is hyper-focused on generative AI in healthcare, pushing forward research to advance gen AI capabilities that can help clinicians in medical decision-making, understand lab and imaging information and provide consumers with personalized health insights based on their wearable data.
STAT
MARCH 19, 2024
Since colorectal cancer is on the rise in people younger than age 50, national guidelines have recently pushed the starting age for colorectal cancer screening down to 45. We need to spread the word. Yet we specialists continue to provide outdated and disproven recommendations on colonoscopy bowel preparation that make the process more difficult for the millions of patients who undergo colonoscopy every year: We tell them to adopt a clear liquid diet the day before their procedure.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MARCH 19, 2024
LONDON — AstraZeneca said Tuesday it would acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on the booming area of targeted radiation therapies for cancer. AstraZeneca will pay $2 billion in cash upfront for Fusion, a price that at $21 a share is nearly double Fusion’s closing share price on Monday.
Fierce Healthcare
MARCH 19, 2024
Google Health unveiled an open-access dataset of real-world dermatology images in partnership with Stanford Medicine. | Thousands of people contributed their images of skin, hair and nail conditions to the Skin Condition Image Network (SCIN) for a diverse dataset reflecting various skin tones, ages, settings and condition severities.
Fierce Pharma
MARCH 19, 2024
This year marks Novo Nordisk’s 30th anniversary in China, and it could also be the year the company's red-hot weight loss injection Wegovy (semaglutide) wins approval in the populous East Asian nat | 2024 marks Novo Nordisk’s 30th anniversary in China, and it could also be the year the Danish drugmaker’s red-hot weight loss injection Wegovy (semaglutide) wins approval in the populous East Asian nation.
Fierce Healthcare
MARCH 19, 2024
The Centers for Disease Control and Prevention (CDC)’s campaign against healthcare worker burnout took a step forward this week with the release of a new instructional guide for executive-level hos | The free resource was developed alongside the Dr. Lorna Breen Heroes' Foundation and informed by a six-month, six-hospital pilot across CommonSpirit Health facilities.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
MARCH 19, 2024
UnitedHealth Group appears to be offering some providers more substantial loans in the wake of the cyberattack on Change Healthcare, according to three doctors who each saw their advances increase up to seven figures. The apparent change comes as hospitals, doctors, and lobbying groups have for weeks complained about low offers from the company, in some cases less than 1% of their typical weekly billing.
Fierce Healthcare
MARCH 19, 2024
Elevance Health has inked a deal to acquire Kroger Specialty Pharmacy. | The grocery chain announced Monday that an agreement is in place, saying it's expected to close in the back half of 2024 pending regulatory approvals.
STAT
MARCH 19, 2024
Nobody has made more of an impact on methadone treatment than Mark Parrino. For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.
pharmaphorum
MARCH 19, 2024
Learn how AI and enhanced medical affairs roles are transforming the landscape of drug development and patient engagement in the health industry. Explore the benefits and advancements in this exciting field.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MARCH 19, 2024
Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found. The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD.
pharmaphorum
MARCH 19, 2024
As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not just the inequalities in women’s health, but female leaders within life sciences, too.
Fierce Pharma
MARCH 19, 2024
After a year marked by Gilead's oncology push and an ongoing focus on CAR-T therapies, CEO Daniel O’Day collected his largest total compensation package since the year he arrived at the Califo | The CEO collected his highest total compensation package since his first year in the role in 2019.
pharmaphorum
MARCH 19, 2024
Discover the key strategies for managing the challenges and embracing the opportunities of EU-wide Health Technology Assessment (HTA) in partnership with the European Medicines Agency (EMA) and prospective market authorisation holders (pMAHs).
Fierce Pharma
MARCH 19, 2024
Guiding AbbVie through an extraordinary decade-plus, riding the success of juggernaut inflammatory disease drug Humira and softening the landing upon its decline, Richard Gonzalez continues to reap | In his final full year as AbbVie’s CEO, Richard Gonzalez pulled down a compensation package worth $25.7 million, according to the company’s proxy filing.
The Checkup by Singlecare
MARCH 19, 2024
A urinary tract infection (UTI) can cause significant discomfort, from a nagging ache in your lower abdomen to a burning sensation that makes urinating feel excruciating. A UTI is most often caused by bacteria in the colon that enter the urinary system, a UTI can affect the urethra, bladder, kidneys, or ureters. Risk factors include being female, engaging in sexual intercourse, having a history of UTIs, using certain types of birth control (like diaphragms or spermicide), and decreasing estrogen
STAT
MARCH 19, 2024
Rise and shine, everyone, another busy day is on the way. Already, the official mascots are racing about the Pharmalot campus in search of breakfast and a steady stream of traffic can be heard nearby. As for us, we are engaged in the usual rituals, starting with brewing cups of stimulation. Our choice today is salted caramel, a veritable whiff of the Jersey shore.
Fierce Pharma
MARCH 19, 2024
In moments of great uncertainty, sometimes the best approach is to just press on. | CDMO WuXi AppTec reported solid performance in 2023 and expects good things for the coming year, too. Still, the Chinese contract manufacturer finds itself embroiled in a national security crackdown in the U.S., where a proposed law threatens to upend WuXi's business.
Fierce Healthcare
MARCH 19, 2024
The upcoming crop of soon-to-be physicians learned on Friday where they would spend their residencies. Match Day 2024 saw record-high applicants and residency positions offered. | The upcoming crop of soon-to-be physicians learned on Friday where they would spend their residencies. Match Day 2024 saw record-high applicants and residency positions offered.
Drug Topics
MARCH 19, 2024
Despite the significant growth of biosimilars, their adoption across various therapeutic areas has remained slow.
Pharmaceutical Commerce
MARCH 19, 2024
In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC talks about his 'Health Equity Spotlight' panel and advocacy accomplishments.
Fierce Pharma
MARCH 19, 2024
After a two-year stint under Merck & Co. veteran Frank Clyburn, New York’s International Flavors & Fragrances (IFF) is stripping away a major component of its healthcare persona. | New York's IFF—which dabbles in food, beverage, beauty and pharmaceutical supply chains, among others—has agreed to sell its pharma solutions business to French plant-based ingredient maker Roquette for up to $2.85 billion.
Digital Pharmacist
MARCH 19, 2024
Younger patients are already beginning to dictate the course of modern healthcare, yet they are rarely the focus of pharmacies’ marketing efforts. Their focus on holistic health and lifestyle-based solutions have contributed to an emphasis on mental health and to recent upticks in organic and wellness trends. Pharmacies can take a long-term approach to marketing by closely looking at who their younger patients are and what they need from their local pharmacy.
European Pharmaceutical Review
MARCH 19, 2024
Under a new deal, Novartis has agreed to acquire US-based biopharma company IFM Therapeutics, for a total of up to $835 million. As part of this new agreement, Novartis has exercised its option to acquire all outstanding capital stock of IFM Due, a subsidiary company of IFM. Therefore, under the acquisition, Novartis has full rights to IFM Due’s portfolio of small molecule Stimulator of Interferon Genes (STING) antagonists, IFM confirmed.
Fierce Pharma
MARCH 19, 2024
Twelve years after Takeda's Iclusig (ponatinib) earned a restricted FDA approval to treat certain patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL), the U.S. | Twelve years after Takeda's Iclusig earned a restricted FDA approval to treat certain patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL), the U.S. regulator has signed off on a wider use.
pharmaphorum
MARCH 19, 2024
New phase 3 data sets up filings for Bayer's non-hormonal menopause symptom treatment elinzanetant and a challenge to Astellas’ first-to-market Veozah
PioneerRx
MARCH 19, 2024
Pharmacy work is demanding. One minute you’re at the drive thru. The next, you’re answering phone calls or submitting vaccination claims. A day in the pharmacy.
Pharmacy Times
MARCH 19, 2024
To date, this is the only targeted therapy indicated for the treatment of generalized pustular psoriasis.
pharmaphorum
MARCH 19, 2024
AstraZeneca upgrades its radiopharma alliance with Fusion Pharma, opting to buy the biotech outright in a deal worth around $2 billion
STAT
MARCH 19, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a look at a pioneering new gene therapy, the plight of WuXi AppTec, and a rough month for biotech’s neuroscience renaissance.
Expert insights. Personalized for you.
232 
Let's personalize your content